NCT04067531Unknown3 期
Treatment of BV With First Deqularum and Then Direkt After With Vaginal Clindamycin Cream.
Skaraborg Hospital1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2020年8月1日最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- cure of BV
研究概览
简要总结
Treatment of BV with first deqularum cloride and then followed with clindamycin vaginal Cream.
详细描述
The hypoteses is that deqularum cloride takes away the biofilm so that clindamycin will kills the bacteria.
Cure rate will be followed up after 1 month and then after 6 month
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •healthy women with BV
排除标准
- •women treated with antibiotics within 1 month
研究组 & 干预措施
treatment of BV
Other
all patients be treated with first Deqularum then with clindamycin Cream,
干预措施: treatment of BV with first Deqularum and then direkt after with vaginal clindamycin (Drug)
结局指标
主要结局
cure of BV
时间窗: 6 month
cure rate of BV
次要结局
未报告次要终点
研究者
Per-Goran Larsson
professor
Skaraborg Hospital
研究点 (1)
Loading locations...
相似试验
Unknown
2 期
Vaginal Clindamycin Cream Plus Vaginal Probiotic for Bacterial VaginosisBacterial Vaginosis TreatmentNCT03234517Zagazig University200
已完成
不适用
Will Lactobacillus Increase Cure Rate After Treatment of Bacterial Vaginosis and Chronic Vulvovaginal CandidaBacterial VaginosisNCT02295579Skaraborg Hospital50
已完成
不适用
Treatment of BV With Donaxyl and a Molecular Test of CureBacterial VaginosesNCT04057482Skaraborg Hospital58
已完成
2 期
Improved treatment of vulvovaginal candidiasis with Clotrimazole plus probiotic Lacidophilin Vaginal CapsulesTo explore the ability of probiotic Lacidophilin Vaginal Capsules plus Clotrimazole Vaginal Tablets (500mg) in improving the treatment of uncomplicated vulvovaginal candidiasis (VVC)TCTR20190718003Ruifang An42
进行中（未招募）
1 期
Effect of treatment of patients with CLL/SLL with venetoclax and ibrutinib induction followed by ibrutinib and obinutuzumab in patients with residual diseaseMedDRA version: 21.0Level: LLTClassification code 10009310Term: CLLSystem Organ Class: 100000004864Chronic Lymphocytic LeukemiaEUCTR2019-002528-34-NLHOVON Foundation85